BEHAVIORAL EFFECTS AND ABUSE OF DRUGS: ANTIHISTAMINES
BEHAVIORAL EFFECTS AND ABUSE OF DRUGS: ANTIHISTAMINES
批准号:
3208402
负责人:
JACK BERGMAN
金额:
$15.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-08-01 至 1990-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Histamine H1 antagonists are among the most frequently used
drugs in contemporary society and are abused in combination with
opioids by certain drug-dependent populations. Our previous work
has shown that prototypical H1 antagonists have striking effects
on schedule-controlled behavior that can be attenuated by the
dopamine antagonist haloperidol. One major focus of the
proposed research is to evaluate further the role of dopamine-
related actions in the behavioral effects of H1 antagonists by: 1)
comparing the effects of H1 antagonists with those of selective
D1 and D2 agonists and 2) studying how the behavioral effects of
H1 antagonists are altered by selective D1 and D2 antagonists.
We previously have found that selected H1 antagonists can
maintain persistent drug-taking behavior in squirrel monkeys. A
second focus of this project is to extend these findings by: 1)
studying the development of self-administration in drug-naive
subjects, 2) evaluating the effects of self-administered H1
antagonists on other ongoing behavior, and 3) investigating how
the reinforcing effects of H1 antagonists are modified by
dopamine D1 and D2 antagonists. Our ongoing research indicates
that H1 antagonists can potentiate the behavioral effects of
cocaine and caffeine. A third focus of the proposed research is to
extend these studies by systematically determining how H1
antagonists modify the reinforcing and other behavioral effects of
cocaine, caffeine, and nicotine. The final objective of the
proposed research is to continue our evaluation of the behavioral
effects of opioids alone and in combination with histamine H1
antagonists. We will assess interactions between these drug
classes by determining how H1 antagonists modify the reinforcing
and other behavioral effects of pentazocine and other opioids.
Overall, the proposed research will provide needed information
about pharmacological and environmental factors mediating the
behavioral effects of histamine H1 antagonists alone and in
combination with other commonly used drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo characterization of opioid biased agonists
-
批准号:10062935
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2019
-
负责人:JACK BERGMAN
-
依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
-
批准号:10609878
-
项目类别:
-
资助金额:$55.63万
-
财政年份:2019
-
负责人:JACK BERGMAN
-
依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
-
批准号:10399441
-
项目类别:
-
资助金额:$71.84万
-
财政年份:2019
-
负责人:JACK BERGMAN
-
依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
-
批准号:10152566
-
项目类别:
-
资助金额:$71.9万
-
财政年份:2019
-
负责人:JACK BERGMAN
-
依托单位:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
-
批准号:10788187
-
项目类别:
-
资助金额:$117.99万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2020.
-
批准号:10285326
-
项目类别:
-
资助金额:$129.94万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. PURPOSE: TO EXERCISE OPTION QUANTITIES 1
-
批准号:10551131
-
项目类别:
-
资助金额:$116.15万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
HEAL - ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
-
批准号:10619967
-
项目类别:
-
资助金额:$37.51万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
HEAL - ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
-
批准号:10788188
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
IGF::OT::IGF ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2019. PURPOSE: TO EXERCISE OPTION QUANTITIES 1
-
批准号:10038816
-
项目类别:
-
资助金额:$171.08万
-
财政年份:2018
-
负责人:JACK BERGMAN
-
依托单位:
Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
-
批准号:9017987
-
项目类别:
-
资助金额:$42.95万
-
财政年份:2014
-
负责人:JACK BERGMAN
-
依托单位:
Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
-
批准号:8808757
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2014
-
负责人:JACK BERGMAN
-
依托单位:
Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
-
批准号:8694614
-
项目类别:
-
资助金额:$52.83万
-
财政年份:2014
-
负责人:JACK BERGMAN
-
依托单位:
FY14. BASE AWARD; ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS IN NON-HUMAN PRIMATES; POP 12/16/2013-12/15/2014; N01DA-14-8913
-
批准号:9201231
-
项目类别:
-
资助金额:$81.14万
-
财政年份:2013
-
负责人:JACK BERGMAN
-
依托单位:
FY14. BASE AWARD; ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS IN NON-HUMAN PRIMATES; POP 12/16/2013-12/15/2014; N01DA-14-8913
-
批准号:8948501
-
项目类别:
-
资助金额:$84.39万
-
财政年份:2013
-
负责人:JACK BERGMAN
-
依托单位:
FY14. BASE AWARD; ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS IN NON-HUMAN PRIMATES; POP 12/16/2013-12/15/2014; N01DA-14-8913
-
批准号:9004339
-
项目类别:
-
资助金额:$79.08万
-
财政年份:2013
-
负责人:JACK BERGMAN
-
依托单位:
Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
-
批准号:8086328
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2011
-
负责人:JACK BERGMAN
-
依托单位:
Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
-
批准号:8461926
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2011
-
负责人:JACK BERGMAN
-
依托单位:
Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
-
批准号:8977501
-
项目类别:
-
资助金额:$42.34万
-
财政年份:2011
-
负责人:JACK BERGMAN
-
依托单位:
Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
-
批准号:8284323
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2011
-
负责人:JACK BERGMAN
-
依托单位:
海外基金